Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (France)

Index « Auteurs » - entrée « David Saadoun »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
David Popp < David Saadoun < David Simpson  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000101 (2019) Sara Touhami [France] ; Eléonore Diwo [France] ; Pascal Sève [France] ; Salim Trad [France] ; Philip Bielefeld [France] ; Damien Sène [France] ; Sebastien Abad [France] ; Antoine Brézin [France] ; Pierre Quartier [France] ; Isabelle Koné Paut [France] ; Michel Weber [France] ; Christophe Chiquet [France] ; Marie-Hélène Errera [France] ; Jérémie Sellam [France] ; Patrice Cacoub [France] ; Gilles Kaplanski [France] ; Laurent Kodjikian [France] ; Bahram Bodaghi [France] ; David Saadoun [France]Expert opinion on the use of biological therapy in non-infectious uveitis.
000161 (2018) Catherine Chapelon-Abric [France] ; David Saadoun [France] ; Isabelle Marie [France] ; Cloé Comarmond [France] ; Anne Claire Desbois [France] ; Fanny Domont [France] ; Léa Savey [France] ; Patrice Cacoub [France]Sarcoidosis with Takayasu arteritis: a model of overlapping granulomatosis. A report of seven cases and literature review.
000194 (2018) Arsene Mekinian [France] ; Mathieu Resche-Rigon [France] ; Cloé Comarmond [France] ; Alessandra Soriano ; Joel Constans [France] ; Laurent Alric [France] ; Patrick Jego [France] ; Florian Busato [France] ; Matthieu Cabon [France] ; Robin Dhote [France] ; Lazaro Estibaliz [France] ; Isabelle Koné-Paut [France] ; Cédric Landron [France] ; Christian Lavigne [France] ; Bertrand Lioger [France] ; Martin Michaud [France] ; Marc Ruivard [France] ; Karim Sacre [France] ; Jacques Eric Gottenberg [France] ; Francis Gaches [France] ; Tiphaine Goulenok [France] ; Carlo Salvarani ; Patrice Cacoub [France] ; Olivier Fain [France] ; David Saadoun [France]Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients.
000222 (2017) Elina Zuelgaray ; Fanny Domont [France] ; Nathan Peiffer-Smadja [France] ; David Saadoun [France] ; Patrice Cacoub [France]Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease: A Case Report
000233 (2017) Elina Zuelgaray [France] ; Fanny Domont [France] ; Nathan Peiffer-Smadja [France] ; David Saadoun [France] ; Patrice Cacoub [France]Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease.
000326 (2016) David Saadoun [France] ; Patrice Cacoub [France]Moving towards new treatments for vasculitis.
000745 (????) Matthias Papo [France] ; Philip Bielefeld ; Hélène Vallet ; Pascal Seve ; Bertrand Wechsler ; Patrice Cacoub ; Phuc Le Hoang ; Thomas Papo ; Bahram Bodaghi ; David SaadounTocilizumab in severe and refractory non-infectious uveitis.

List of associated KwdEn.i

Nombre de
documents		Descripteur
6Humans
4Female
4Immunosuppressive Agents (therapeutic use)
4Middle Aged
3Adult
3Treatment Outcome
2Antibodies, Monoclonal, Humanized (adverse effects)
2Antibodies, Monoclonal, Humanized (therapeutic use)
2Male
2Takayasu Arteritis (drug therapy)
2Uveitis (drug therapy)
1Adalimumab (therapeutic use)
1Aged
1Anti-Inflammatory Agents (administration & dosage)
1Anti-Inflammatory Agents (adverse effects)
1Antibodies, Monoclonal (therapeutic use)
1Antibodies, Monoclonal, Humanized (administration & dosage)
1Antirheumatic Agents (therapeutic use)
1Behcet Syndrome (complications)
1Behcet Syndrome (drug therapy)
1Biological Factors (pharmacology)
1Biological Factors (therapeutic use)
1C-Reactive Protein (metabolism)
1Drug Design
1Drug Hypersensitivity Syndrome (etiology)
1Drug Resistance
1Follow-Up Studies
1France
1Granuloma (complications)
1Granuloma (diagnosis)
1Granuloma (drug therapy)
1Granuloma (immunology)
1Immunosuppressive Agents (pharmacology)
1Infliximab (therapeutic use)
1Prednisone (therapeutic use)
1Remission Induction
1Retrospective Studies
1Review
1Sarcoidosis (complications)
1Sarcoidosis (diagnosis)
1Sarcoidosis (drug therapy)
1Sarcoidosis (immunology)
1Severity of Illness Index
1Sirolimus (therapeutic use)
1Still's Disease, Adult-Onset (drug therapy)
1Survival Analysis
1Takayasu Arteritis (complications)
1Takayasu Arteritis (diagnosis)
1Takayasu Arteritis (immunology)
1Takayasu Arteritis (mortality)
1Time Factors
1Uveitis (etiology)
1Uveitis (pathology)
1Vasculitis (drug therapy)
1Vasculitis (physiopathology)
1Vitrectomy
1Young Adult
1adalimumab
1azathioprine
1biological product
1biological therapy
1human
1immunosuppressive agent
1infliximab
1interferon
1mycophenolate mofetil
1rapamycin
1steroid
1tocilizumab
1uveitis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "David Saadoun" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "David Saadoun" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    David Saadoun
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021